CIBC World Market
FOLD

CIBC World Market’s Amicus Therapeutics FOLD Stock Holding History

CIBC World Market’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,216
Closed -$511K – 1281
2020
Q3 		$511K Buy
36,216
+549
+2% +$8K ﹤0.01% 813
2020
Q2 		$538K Buy
+35,667
New +$435K ﹤0.01% 775

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Market's FOLD Position: Q4 2020 in Review

CIBC World Market sold out of Amicus Therapeutics (FOLD) in Q4 2020, closing a stake of 36,216 shares — an estimated $511K sold.

CIBC World Market first reported a position in FOLD in Q2 2020 and held it in 2 quarters. The position peaked at $538K in Q2 2020. 272 funds tracked by Wall St. Rank hold FOLD as of Q4 2020.

  • CIBC World Market reported no remaining Amicus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • CIBC World Market sold 36,216 Amicus Therapeutics shares in Q4 2020, an estimated $511K.
  • CIBC World Market first reported a position in Amicus Therapeutics in Q2 2020 and held it in 2 quarters.
  • CIBC World Market's Amicus Therapeutics position peaked at $538K in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2020.

Based on CIBC World Market's 13F filing for Q4 2020, filed 8 Feb 2021.